Horm Metab Res 2003; 35(3): 137-141
DOI: 10.1055/s-2003-39073
Original Basic

© Georg Thieme Verlag Stuttgart · New York

Effects of Estradiol and Progesterone on Vertebral Collagen, Glycosaminoglycans and Phosphatases in Ovariectomized Adult Rats

V.  Gopala Krishnan1 , J.  Arunakaran1 , P.  Govindarajulu1 , N.  Srinivasan1
  • 1Department of Endocrinology, Dr. Alm Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, India
Further Information

Publication History

Received 28 May 2002

Accepted after revision 25 October 2002

Publication Date:
07 May 2003 (online)

Abstract

Vertebral collagen, glycosaminoglycans (GAGs), tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (ALP) were measured in ovariectomized (ovx) adult Wistar rats treated with estradiol (E2) (10 µg/kg BW for 35 days on alternate days, and progesterone (P4) (140 µg/kg BW for 35 days on alternate days) in E2 + P4 treated rats. P4 given alone or in combination with E2 significantly increased the levels of collagen in the vertebral bone. Neither ovx nor E2 treatment altered the concentration of collagen in these rats. Administration of E2 or P4 significantly decreased the concentration of hyaluronic acid (HA), but remaining unaffected when a combination of these steroids was given. In contrast to their effect on HA, E2 and P4 each significantly increased the levels of chondroitin sulfate (CS) in the vertebral bone. The specific activity of ALP was decreased after ovx. E2 and P4 alone or in combination also registered a significant decrease in the activities of ALP and TRAP. The results suggest that E2 and P4 each exert definite effects on vertebral bone turnover in ovariectomized rats.

References

  • 1 Albright F. Osteoporosis.  Ann Int Med. 1947;  27 862
  • 2 Yamasaki D, Enokida M, Okano T, Hagino H, Teshima R. Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis.  Bone. 2001;  28 634-640
  • 3 Christiansen C, Christensen M S, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.  Lancet. 1981;  1 459-461
  • 4 Gotfredsen A, Nilas L, Riis B J, Thomsen K, Christiansen C. Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: a local or generalised phenomenon?.  Br Med J (Clin Res Ed).. 1986;  292 1098-1100
  • 5 Lindsay R, Hart D M, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women.  Lancet. 1980;  2 1151-1154
  • 6 Ho K K, Weissberger A J. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.  J Bone Miner Res. 1992;  7 821-827
  • 7 Lukert B P, Johnson B E, Robinson R G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.  J Bone Miner Res. 1992;  7 1063-1069
  • 8 Eriksen E F, Colvard D S, Berg N J, Graham M L, Mann K G, Spelsberg T C, Riggs B L. Evidence of estrogen receptors in normal human osteoblast-like cells.  Science. 1988;  241 84-86
  • 9 Komm B S, Terpening C M, Benz D J, Graeme K A, Gallegos A, Korc M, Greene G L, O'Malley B W, Haussler M R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.  Science. 1988;  241 81-84
  • 10 Pensler J M, Radosevich J A, Higbee R, Langman C B. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors.  J Bone Miner Res. 1990;  5 797-802
  • 11 Christiansen C, Nilas L, Riis B J, Rodbri P, Deftos L J. Uncoupling of bone formation and resorption by combined estrogen and progesterone therapy in postmenopausal osteoporosis.  Lancet. 1985;  2 800-801
  • 12 MacNamara P, O'Shaughnessy C, Manduca P, Loughrey H C. Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures.  Calcif Tissue Int. 1995;  57 436-441
  • 13 Luo X H, Liao E Y. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1-MMP) compartment of proMMP-2 activation in MG-63 cells.  Horm Metab Res. 2001;  33 383-388
  • 14 Fisher E C, Nelson M E, Frontera W R, Turksoy R N, Evans W J. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women.  J Clin Endocrinol Metab. 1986;  62 1232-1236
  • 15 Drinkwater B L, Bruemner B, Chesnut C H. Menstrual history as a determinant of current bone density in young athletes.  JAMA. 1990;  263 545-548
  • 16 Chow J, Tobias J H, Colston K W, Chambers T J. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.  J Clin Invest. 1992;  89 74-78
  • 17 Broulik P D. Tamoxifen prevents bone loss in castrated male mice.  Horm Metab Res. 2000;  32 181-184
  • 18 Zarrow M X, Yochim J M, McCarthy J L. In: Experimental Endocrinology. A source book of basic techniques. New York; Academic Press 1964: 39-44
  • 19 Gaumet N, Braillon P, Seibel M J, Pointillart A, Coxam V, Davicco M J. Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats.  Gerontology. 1998;  44 132-139
  • 20 Trandeau F J, Freiere F. Estimation of serum and urinary calcium.  Clin Chem. 1967;  13 101-103
  • 21 Andersch M A, Szecypinski A J. Use of p-nitrophenol phosphatase as the substrate for determination of serum acid phosphatase.  Am J Clin Pathol. 1947;  17 571-574
  • 22 Tenniswood M, Bird C E, Clark A F. Acid phosphatases: androgen dependent markers of rat prostate.  Can J Biochem. 1976;  54 350-357
  • 23 Lowry O H, Rosebrough N J, Far A B, Randall R J. Protein measurements with follin-phenol reagent.  J Biol Chem. 1951;  193 265-275
  • 24 Stegemann H. Hoppe-Seylers Z.  Physiol Chem. 1958;  311 41
  • 25 Takeuchi J, Sobu M, Sato E, Shamoto M, Miura K, Nakagaki S. Variation in glycosaminoglycan components of breast tumours.  Cancer Res. 1976;  36 2133-2139
  • 26 Homer K A, Denbow L, Beighton D. Spectrophotometric method for the assay of glycosaminoglycans and glycosaminoglycan-depolymerizing enzymes.  Anal Biochem. 1993;  21 435-441
  • 27 Benchetrit L C, Pahiya S L, Gray E D, Edstrom R D. A simple method for hyaluronidase assay.  Anal Biochem. 1977;  79 431-437
  • 28 Zar J H. Multiway functional analysis of variance. In: Zar JH (ed) Biol Statististical analysis. New Jersey; second Inc Englewood Cliffs 1974: 1-718
  • 29 Dalsky G P. Effect of exercise on bone: permissive influence of estrogen and calcium.  Med Sci Sports Exerc. 1990;  22 281-285
  • 30 Oursler M J, Osdoby P, Pyfferoen J, Riggs B L, Spelsberg T C. Avian osteoclasts as estrogen target cells.  Proc Natl Acad Sci USA.. 1991;  88 6613-6617
  • 31 Hoyland J A, Mee A P, Baird P, Braidman I P, Mawer E B, Freemont A J. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction.  Bone. 1997;  20 87-92
  • 32 MacNamara P, Loughrey H C. Molecular and cellular biology of the bone. Presented at the 63rd meeting held at Galway, 3 - 5 September 1997
  • 33 Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee L J, Tanaka H, Seino Y. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.  J Bone Miner Res. 1995;  10 1853-1864
  • 34 Wronski T J, Cintron M, Doherty A L, Dann L M. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats.  Endocrinology.. 1988;  123 681-686
  • 35 Turner R T, Riggs B L, Spelsberg T C. Skeletal effects of estrogen.  Endocr Rev. 1994;  15 275-300
  • 36 Cheng M Z, Zaman G, Lanyon L E. Estrogen enhances the stimulation of bone collagen synthesis by loading and exogenous prostacyclin, but not prostaglandin E2, in organ cultures of rat ulnae.  J Bone Miner Res. 1994;  9 805-816
  • 37 Danielsen C C, Mosekilde L I, Svenstrup B. Cortical bone mass, composition and mechanical properties in female rats in relation to age, long-term ovariectomy and estrogen substitution.  Calcif Tissue Int. 1992;  52 26-33
  • 38 Hynes R O. The molecular biology of firbronectin.  Ann Rev Cell Biol. 1985;  1 67-90
  • 39 Frazier W A. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells.  J Cell Biol. 1987;  105 625-632
  • 40 Sage E H, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC tenascin and thrombospondin.  J Biol Chem. 1991;  266 14 831-14 834
  • 41 Hook M, Woods A, Johansson S, Kjellen L, Couchman J R. Functions of proteoglycans at the cell surface.  Ciberfound-sympon. 1986;  124 143-157
  • 42 Wood G G. The formation of fibrils from collagen solutions. 3 - Effect of chondroitin sulphate and polyanions on the rate of formation.  Biochem J. 1960;  75 605-612
  • 43 Steven F S, Knott J, Jackson D S, Podrasky V. Collagen-protein polysaccharide interactions in human intervertebral disc.  Biochim Biophy Acta. 1969;  188 307-313
  • 44 Scott J E, Orford C R, Hughes E W. Proteoglycan-collagen arrangements in developing rat tail tendon. An electron microscopical and biochemical investigation.  Biochem J. 1981;  195 573-581
  • 45 Scott J E. Proteoglycan-fibrillar collagen interactions.  Biochem J. 1988;  252 313-323

Dr. N. Srinivasan

Dr. Alm Post Graduate Institute of Basic Medical Sciences · University of Madras

Taramani · Chennai 600 113 · India

Phone: + 91 (44) 24480784

Fax: + 91 (44) 4926709

Email: n_srini2000@yahoo.com

    >